Borderline personality disorder, stigma, and treatment implications

被引:209
|
作者
Aviram, Ron B.
Brodsky, Beth S.
Stanley, Barbara
机构
[1] New York State Psychiat Inst & Hosp, New York, NY 10032 USA
[2] William Alanson White Inst Psychiat Psychoanal & P, New York, NY USA
[3] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
[4] CUNY John Jay Coll Criminal Justice, New York, NY 10019 USA
关键词
attrition; borderline personality disorder; countertransference; outcome; personality disorder; psychotherapy; self-injury; stigma; stigmatization; suicide;
D O I
10.1080/10673220600975121
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Borderline personality disorder (BPD) is often viewed in negative terms by mental health practitioners and the public. The disorder may have a stigma associated with it that goes beyond those associated with other mental illnesses. The stigma associated with BPD may affect how practitioners tolerate the actions, thoughts, and emotional reactions of these individuals. It may also lead to minimizing symptoms and overlooking strengths. In society, people tend to distance themselves from stigmatized populations, and there is evidence that some clinicians may emotionally distance themselves from individuals with BPD. This distancing may be especially problematic in treating patients with BPD; in addition to being unusually sensitive to rejection and abandonment, they may react negatively (e.g., by harming themselves or withdrawing from treatment) if they perceive such distancing and rejection. Clinicians' reactivity may be self-protective in response to actual behavior associated with the pathology. As a consequence, however, the very behaviors that make it difficult to work with these individuals contribute to the stigma of BPD. In a dialectical relationship, that stigma can influence the clinician's reactivity, thereby exacerbating those same negative behaviors. The result is a self-fulfilling prophecy and a cycle of stigmatization to which both patient and therapist contribute. The extent to which therapist distancing is influenced by stigma is an important question that highlights the possibility that the stigma associated with BPD can have an independent contribution to poor outcome with this population. A final issue concerns the available means for identifying and limiting the impact of stigmatization on the treatment of individuals with BPD.
引用
收藏
页码:249 / 256
页数:8
相关论文
共 50 条
  • [21] Treatment Advances in Borderline Personality Disorder
    Nelson, Katharine J.
    Schulz, S. Charles
    PSYCHIATRIC ANNALS, 2012, 42 (02) : 59 - 64
  • [22] Venlafaxine in the treatment of borderline personality disorder
    Markovitz, PJ
    Wagner, SC
    PSYCHOPHARMACOLOGY BULLETIN, 1995, 31 (04) : 773 - 777
  • [23] Quetiapine in the treatment of borderline personality disorder
    Hilger, E
    Barnas, C
    Kasper, S
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S329 - S329
  • [24] Fluoxetine in the treatment of borderline personality disorder
    Silva, H
    Jerez, S
    Paredes, A
    Salvo, J
    Renteria, P
    Ramirez, A
    Montes, C
    ACTAS LUSO-ESPANOLAS DE NEUROLOGIA PSIQUIATRIA Y CIENCIAS AFINES, 1997, 25 (06): : 391 - 395
  • [25] Treatment of borderline personality disorder with risperidone
    Rocca, P
    Marchiaro, L
    Cocuzza, E
    Bogetto, F
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (03) : 241 - 244
  • [26] Integrated treatment for borderline personality disorder
    Oldham, John M.
    PSYCHIATRIC ANNALS, 2006, 36 (05) : 361 - +
  • [27] Psychopathology and treatment of borderline personality disorder
    Bohus, M.
    Schmahl, C.
    NERVENARZT, 2007, 78 (09): : 1069 - 1080
  • [28] Quetiapine in the treatment of borderline personality disorder
    Hilger, E
    Barnas, C
    Kasper, S
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2003, 4 (01): : 42 - 44
  • [29] Pharmacological treatment of borderline personality disorder
    Chavez-Leon, Enrique
    Ng, Bernardo
    Ontiveros-Uribe, Martha Patricia
    SALUD MENTAL, 2006, 29 (05) : 16 - 24
  • [30] Psychopharmacological treatment in borderline personality disorder
    Diaz-Marsa, M.
    Bardanca, S. Gonzlez
    Tajima, K.
    Garcia-Albea, J.
    Navas, M.
    Carrascol, J. L.
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2008, 36 (01): : 39 - 49